Product Information

PAROXETINE CR 25 MG TABLET is a generic product labeled by Apotex Corp., priced at $0.4061 per EA under NDC 60505131703. Its NADAC has been published 336 times since Mar 18, 2020.

FDA first approved this application on Feb 16, 1999. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the paroxetine hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

PAROXETINE CR 25 MG TABLET

paroxetine hydrochloride
$0.4061per EA
High Outlier

Strength

25 mg/1

Manufacturer

Apotex Corp.

NDC

60505131703

Classification

Generic

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Approval Type

Authorized Generic (NDA)

FDA Application

NDA020936

FDA Approved

2/16/1999

TE Code

AB

On Market Since

8/9/2019

Pharmacological Classes

Serotonin Reuptake Inhibitor
Serotonin Uptake Inhibitors

Price Statistics

The NADAC for PAROXETINE CR 25 MG TABLET has been published 336 times since Mar 18, 2020, and over the history we have for it it has declined 73.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.4061 per EA
All-time high$1.5513 (Apr 15, 2020)
All-time low$0.3584 (Nov 20, 2024)
52-week high$0.5084
52-week low$0.3809
Median price$0.7473
Average price$0.7837
Largest weekly change+53.5% (Jul 19, 2023)
Weeks tracked336
Tracking sinceMar 18, 2020

Price History

1W

-1.4%

1M

-1.4%

3M

+6.6%

6M

-14.2%

1Y

-9.9%

3Y

-61.5%

5Y

-65.9%

All

-73.8%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of PAROXETINE CR 25 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for PAROXETINE CR 25 MG TABLET, manufactured by Apotex Corp., is $0.4061 per EA (NDC 60505131703), effective Aug 19, 2026.

How has the price of PAROXETINE CR 25 MG TABLET changed over time?

Over the history we have for it, the NADAC for PAROXETINE CR 25 MG TABLET has declined 73.8%. It has been tracked across 336 weekly CMS publications since Mar 18, 2020.

What are the highest and lowest recorded NADAC prices for PAROXETINE CR 25 MG TABLET?

Since Mar 18, 2020, the NADAC for PAROXETINE CR 25 MG TABLET has ranged from a low of $0.3584 (Nov 20, 2024) to a high of $1.5513 (Apr 15, 2020), with a median of $0.7473 per EA.

Are there cheaper alternatives to PAROXETINE CR 25 MG TABLET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as PAROXETINE CR 25 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures PAROXETINE CR 25 MG TABLET?

PAROXETINE CR 25 MG TABLET (NDC 60505131703) is labeled by Apotex Corp., and CMS classifies it as a generic product.